Skip to main content

Scientists from IRB Barcelona and CNIO assemble the γ-tubulin ring complex in vitro for the first time

Images

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

This work paves the way for the in vitro study of the nucleation process that is essential for assembly and organisation of the microtubule cytoskeleton.

The paper is a collaboration between Jens Lüders’ group at IRB Barcelona and Oscar Llorca’s at CNIO.

The results have been published in Science Advances.

Researchers from the Microtubule Organization lab, headed by Jens Lüders at IRB Barcelona, and the Macromolecular Complexes in DNA Damage Response Group, led by Oscar Llorca at the Spanish National Cancer Research Centre (CNIO), have achieved the first in vitro reconstitution of the human -tubulin ring complex (γTuRC), responsible for initiating microtubule formation. In addition, they revealed its 3D structure by cryo-electron microscopy. The key to their success lies in the identification of the RUVBL protein complex as an essential γTuRC assembly helper.

Microtubules are a component of the cytoskeleton, which is essential for intracellular transport processes and cell division. Microtubules cannot form spontaneously in cells but require nucleation by the γTuRC. Mutations in γTuRC subunits cause neurodevelopmental defects such as microcephaly and have also been linked to defects in the retina.

“Although the γTuRC was discovered 25 years ago, the field had not been successful in producing it recombinantly in vitro,” says co-corresponding author Jens Lüders, “this new achievement opens the door to studies aimed at elucidating the microtubule nucleation mechanism and how it is regulated”. It will also allow the study of the mutations found in patients and predictions of their effects, to better understand how they cause disease.

 

The RUVBL protein complex, essential for the construction of the γTuRC

The difficulty to assemble the γTuRC in vitro is due not only to its complex 3D structure but also to the need of RUVBL for the assembly and formation of the ring-shaped TuRC. “When I started this project I analyzed previously published data, and noticed that a requirement for RUVBL in γTuRC assembly had never been considered before – it was very gratifying to see that this was indeed the key to our success” explains first author Fabian Zimmerman, PhD student in the Microtubule Organization lab at IRB Barcelona.

“Our group has been exploring the function of RUVBL in the assembly of large macromolecular structures relevant to cancer for years. Discovering that RUVBL is also essential for the formation of γTuRC opens new avenues of research to understand how cells build complex functional structures,”  says co-corresponding author Oscar Llorca.

“ γTuRC is a very large structure built by multiple and interconnected subunits. Determining its 3D architecture has been an immense challenge, made possible by advances in cryo-electron microscopy methods that allowed us to observe individual molecules of this complex with extremely high detail ”, explains co-first author Marina Serna.

This work has been supported by the Spanish Ministry of Science, Innovation and Universities (MCIU/AEI), the National Institute of Health Carlos III, the European Regional Development Fund (ERDF), the support of the National Institute of Health Carlos III to CNIO, the Autonomous Region of Madrid, ”la Caixa” Foundation and the European Union’s Horizon 2020 research and innovation program under a Marie Skłodowska-Curie grant.

 

Reference article:

Fabian Zimmermann, Marina Serna, Artur Ezquerra, Rafael Fernandez-Leiro, Oscar Llorca & Jens Luders
Assembly of the asymmetric human γ-tubulin ring complex by RUVBL1-RUVBL2 AAA ATPase
Science Advances (2020) DOI: 10.1126/sciadv.abe0894

 

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).